Targets and Emerging Therapies for Schizophrenia Albert Hardback Wiley–Blackwell

Targets and Emerging Therapies for SchizophreniaAuthor(s): Jeffrey S. Albert, Michael W. Wood\nFormat: Hardback\nPublisher: John Wiley & Sons Inc, United States\nImprint: John Wiley & Sons Inc\nISBN-13: 9780470322826, 978-0470322826\nSynopsis\nNew and emerging directions in pharmaceutical research to better treat schizophrenia\n\n Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and pharmacology, this book explores emerging directions in pharmaceutical research for drug targeting and discovery in order to find more effective treatments for schizophrenia, one of the most serious and widespread psychiatric diseases.\n\n Targets and Emerging Therapies for Schizophrenia presents the basics of schizophrenia, drug targets for the disease, and potent.